137 related articles for article (PubMed ID: 35861939)
21. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
[TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA LINC00675 inhibits tumorigenesis and EMT via repressing Wnt/β-catenin signaling in esophageal squamous cell carcinoma.
Zhong YB; Shan AJ; Lv W; Wang J; Xu JZ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8288-8297. PubMed ID: 30556869
[TBL] [Abstract][Full Text] [Related]
23. L1CAM drives oncogenicity in esophageal squamous cell carcinoma by stimulation of ezrin transcription.
Guo JC; Xie YM; Ran LQ; Cao HH; Sun C; Wu JY; Wu ZY; Liao LD; Zhao WJ; Fang WK; Li EM; Xu LY; Schachner M; Xie JJ
J Mol Med (Berl); 2017 Dec; 95(12):1355-1368. PubMed ID: 28939985
[TBL] [Abstract][Full Text] [Related]
24. LncRNA DDX11 antisense RNA 1 promotes EMT process of esophageal squamous cell carcinoma by sponging miR-30d-5p to regulate SNAI1/ZEB2 expression and Wnt/β-catenin pathway.
Guo Y; Sun P; Guo W; Yin Q; Han J; Sheng S; Liang J; Dong Z
Bioengineered; 2021 Dec; 12(2):11425-11440. PubMed ID: 34866524
[TBL] [Abstract][Full Text] [Related]
25. FBXO31 determines poor prognosis in esophageal squamous cell carcinoma.
Kogo R; Mimori K; Tanaka F; Komune S; Mori M
Int J Oncol; 2011 Jul; 39(1):155-9. PubMed ID: 21537837
[TBL] [Abstract][Full Text] [Related]
26. [The expression of p53, p16, cyclin D1 in esophageal squamous cell carcinoma and esophageal dysplasia].
Kim SG; Hong SJ; Kwon KW; Jung SW; Kim WY; Jung IS; Ko BM; Ryu CB; Kim YS; Moon JH; Kim JO; Cho JY; Lee JS; Lee MS; Shim CS; Kim BS
Korean J Gastroenterol; 2006 Oct; 48(4):269-76. PubMed ID: 17060721
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of KIF18B facilitates malignant phenotype of esophageal squamous cell carcinoma by activating CDCA8/mTORC1 pathway.
Xie J; Wang B; Luo W; Li C; Jia X
J Clin Lab Anal; 2022 Oct; 36(10):e24633. PubMed ID: 36085568
[TBL] [Abstract][Full Text] [Related]
28. SOX12 contributes to the activation of the JAK2/STAT3 pathway and malignant transformation of esophageal squamous cell carcinoma.
Li C; Zhu M; Zhu J; Lu Q; Shi B; Sun B; Chen H
Oncol Rep; 2021 Jan; 45(1):129-138. PubMed ID: 33416144
[TBL] [Abstract][Full Text] [Related]
29. SET domain-containing 5 is a potential prognostic biomarker that promotes esophageal squamous cell carcinoma stemness.
Piao L; Li H; Feng Y; Yang Z; Kim S; Xuan Y
Exp Cell Res; 2020 Apr; 389(1):111861. PubMed ID: 31981592
[TBL] [Abstract][Full Text] [Related]
30. TEX9 and eIF3b functionally synergize to promote the progression of esophageal squamous cell carcinoma.
Xu F; Zhang S; Liu Z; Gu J; Li Y; Wang L; Mao W; Zhu Q; Shou H; Ge D; Lu C
BMC Cancer; 2019 Sep; 19(1):875. PubMed ID: 31481019
[TBL] [Abstract][Full Text] [Related]
31. [FAT1 inhibits cell proliferation of esophageal squamous cell carcinoma through regulating the expression of CDK4/CDK6/CCND1 complex].
Hu XL; Zhai YF; Li GD; Xing JF; Yang J; Bi YH; Wang J; Shi RY
Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):14-20. PubMed ID: 29365412
[No Abstract] [Full Text] [Related]
32. RASSF10 exhibits tumor‑suppressing potential involving tumor proliferation, metastasis and epithelial‑mesenchymal transition in esophageal squamous cell carcinoma.
Liu Y; Zhu X; Zhang W; Bian T; Wu Z; Zhang J; Qiu H; Hu Y; Feng J; Shi J
Oncol Rep; 2022 Apr; 47(4):. PubMed ID: 35211758
[TBL] [Abstract][Full Text] [Related]
33. Circular RNA circNTRK2 facilitates the progression of esophageal squamous cell carcinoma through up-regulating NRIP1 expression via miR-140-3p.
Chen X; Jiang J; Zhao Y; Wang X; Zhang C; Zhuan L; Zhang D; Zheng Y
J Exp Clin Cancer Res; 2020 Jul; 39(1):133. PubMed ID: 32653032
[TBL] [Abstract][Full Text] [Related]
34. Knockdown of lncRNAXLOC_001659 inhibits proliferation and invasion of esophageal squamous cell carcinoma cells.
Li FZ; Zang WQ
World J Gastroenterol; 2019 Nov; 25(42):6299-6310. PubMed ID: 31754291
[TBL] [Abstract][Full Text] [Related]
35. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway.
Wang H; Yang X; Guo Y; Shui L; Li S; Bai Y; Liu Y; Zeng M; Xia J
J Exp Clin Cancer Res; 2019 Jul; 38(1):324. PubMed ID: 31331361
[TBL] [Abstract][Full Text] [Related]
36. A novel long noncoding RNA, LOC440173, promotes the progression of esophageal squamous cell carcinoma by modulating the miR-30d-5p/HDAC9 axis and the epithelial-mesenchymal transition.
Wang G; Feng B; Niu Y; Wu J; Yang Y; Shen S; Guo Y; Liang J; Guo W; Dong Z
Mol Carcinog; 2020 Dec; 59(12):1392-1408. PubMed ID: 33079409
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of OTX1 promotes tumorigenesis in patients with esophageal squamous cell carcinoma.
Chai J; Xu T; Yang Y; Yuan Y; Xu J; Liu J; Wang K; Lv Y; Chai J; Kang Y; Chen L; Qin J; Jia Q; Li M
Pathol Res Pract; 2022 Apr; 232():153841. PubMed ID: 35303522
[TBL] [Abstract][Full Text] [Related]
38. Knockdown of HOXA5 inhibits the tumorigenesis in esophageal squamous cell cancer.
Zhang H; Zhao JH; Suo ZM
Biomed Pharmacother; 2017 Feb; 86():149-154. PubMed ID: 27960137
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-30c functions as a tumor suppressor via targeting SNAI1 in esophageal squamous cell carcinoma.
Ma T; Zhao Y; Lu Q; Lu Y; Liu Z; Xue T; Shao Y
Biomed Pharmacother; 2018 Feb; 98():680-686. PubMed ID: 29304493
[TBL] [Abstract][Full Text] [Related]
40. Myosin 5a regulates tumor migration and epithelial-mesenchymal transition in esophageal squamous cell carcinoma: utility as a prognostic factor.
Sato N; Fujishima F; Nakamura Y; Aoyama Y; Onodera Y; Ozawa Y; Ito K; Ishida H; Kamei T; Watanabe M; Sasano H
Hum Pathol; 2018 Oct; 80():113-122. PubMed ID: 29898384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
